Source link : https://newshealth.biz/health-news/glp-1-amylin-analog-combo-cuts-blood-sugar-weight-in-diabetes-trials/
NEW ORLEANS — A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and weight in various populations with type 2 diabetes. The combination injectable, dubbed CagriSema, performed well at doses of 2.4 or 1.0 mg of each drug across three phase III double-blind REIMAGINE studies presented at the […]
The post GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-08 19:35:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8